Health-Related Quality of Life in Women Carrying Genetic Variants Associated with Breast Cancer Risk: A Descriptive
Alejandro Oliva-Muñoz1, Manuel Fernández-Alcántara2, Nicolás Ruiz-Robledillo2
1Department of Obstetrics and Gynecology, Doctor Balmis General University Hospital of Alicante, 03010 Alicante, Spain.
Women with genetic risk variants for breast cancer who developed the disease reported lower quality of life and higher anxiety. This group also pursued more risk-reducing surgeries, impacting their satisfaction and physical well-being.
Area of Science:
- Oncology
- Genetics
- Public Health
Background:
- Breast cancer is a leading cancer among Spanish women, with genetic variants increasing risk and impacting quality of life.
- Understanding the health-related quality of life (HRQoL) in women with genetic cancer risk variants is crucial for personalized care.
Purpose of the Study:
- To describe HRQoL in women with breast cancer-associated genetic risk variants, comparing those with and without breast cancer.
- To identify factors influencing decisions regarding risk-reducing surgery in this population.
Main Methods:
- A descriptive study utilizing the BREAST-Q, SF-12, and DASS-21 questionnaires.
- Participants included 63 women with genetic risk variants, categorized by breast cancer diagnosis status.
Main Results:
- Women with breast cancer exhibited significantly lower HRQoL scores in 'Satisfaction with breasts' and 'Physical well-being: chest' (BREAST-Q), and the SF-12 physical component.
- Breast cancer patients reported significantly higher anxiety scores (DASS-21).
- Risk-reducing surgeries (prophylactic mastectomy and adnexectomy) were more common in breast cancer patients, older women, those with children, and postmenopausal women.
Conclusions:
- Pathogenic genetic variants significantly lower health-related quality of life in women who develop breast cancer.
- The findings suggest a link between lower HRQoL and increased uptake of risk-reducing surgeries among affected women.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Cancer Survival Analysis
Disorders of the Female Reproductive System
Cancer Prevention
Some...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...


